TY - JOUR
T1 - Development of the iLiNP Device
T2 - Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
AU - Kimura, Niko
AU - Maeki, Masatoshi
AU - Sato, Yusuke
AU - Note, Yusuke
AU - Ishida, Akihiko
AU - Tani, Hirofumi
AU - Harashima, Hideyoshi
AU - Tokeshi, Manabu
N1 - Funding Information:
This work was supported by JST CREST Grant Number JP17937657, Japan. A part of this work was also supported by the Tokyo Kasei Chemical Promotion Foundation. M. Maeki gratefully acknowledges the Nanotech CUPAL NRP program. The authors acknowledge the technical support provided by Dr. Kobayashi and the Nikon Imaging Center at Hokkaido University in the use of the confocal microscope system and carrying out the image analysis.
Funding Information:
This work was supported by JST CREST Grant Number JP17937657, Japan. A part of this work was also supported by the Tokyo Kasei Chemical Promotion Foundation. M. Maeki gratefully acknowledges the Nanotech CUPAL NRP program.The authors acknowledge the technical support provided by Dr. Kobayashi and the Nikon Imaging Center at Hokkaido University in the use of the confocal microscope system and carrying out the image analysis.
Publisher Copyright:
© Copyright 2018 American Chemical Society.
PY - 2018/5/9
Y1 - 2018/5/9
N2 - The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
AB - The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
UR - http://www.scopus.com/inward/record.url?scp=85046878991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046878991&partnerID=8YFLogxK
U2 - 10.1021/acsomega.8b00341
DO - 10.1021/acsomega.8b00341
M3 - Article
AN - SCOPUS:85046878991
SN - 2470-1343
VL - 3
SP - 5044
EP - 5051
JO - ACS Omega
JF - ACS Omega
IS - 5
ER -